170 related articles for article (PubMed ID: 31393902)
1. Utilisation of the STEAP protein family in a diagnostic setting may provide a more comprehensive prognosis of prostate cancer.
Burnell SEA; Spencer-Harty S; Howarth S; Bodger O; Kynaston H; Morgan C; Doak SH
PLoS One; 2019; 14(8):e0220456. PubMed ID: 31393902
[TBL] [Abstract][Full Text] [Related]
2. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
3. STEAP1 protein overexpression is an independent marker for biochemical recurrence in prostate carcinoma.
Ihlaseh-Catalano SM; Drigo SA; de Jesus CM; Domingues MA; Trindade Filho JC; de Camargo JL; Rogatto SR
Histopathology; 2013 Nov; 63(5):678-85. PubMed ID: 24025158
[TBL] [Abstract][Full Text] [Related]
4. Putative prognostic epithelial-to-mesenchymal transition biomarkers for aggressive prostate cancer.
Whiteland H; Spencer-Harty S; Thomas DH; Davies C; Morgan C; Kynaston H; Bose P; Fenn N; Lewis PD; Bodger O; Jenkins S; Doak SH
Exp Mol Pathol; 2013 Oct; 95(2):220-6. PubMed ID: 23933194
[TBL] [Abstract][Full Text] [Related]
5. A role for STEAP2 in prostate cancer progression.
Whiteland H; Spencer-Harty S; Morgan C; Kynaston H; Thomas DH; Bose P; Fenn N; Lewis P; Jenkins S; Doak SH
Clin Exp Metastasis; 2014 Dec; 31(8):909-20. PubMed ID: 25248617
[TBL] [Abstract][Full Text] [Related]
6. STEAP proteins: from structure to applications in cancer therapy.
Gomes IM; Maia CJ; Santos CR
Mol Cancer Res; 2012 May; 10(5):573-87. PubMed ID: 22522456
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
Kahl P; Gullotti L; Heukamp LC; Wolf S; Friedrichs N; Vorreuther R; Solleder G; Bastian PJ; Ellinger J; Metzger E; Schüle R; Buettner R
Cancer Res; 2006 Dec; 66(23):11341-7. PubMed ID: 17145880
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of six-transmembrane epithelial antigen of the prostate expressed in prostatic carcinoma].
Li L; Li J; Shen Z; Liu W; Chen Z
Zhonghua Nan Ke Xue; 2004 May; 10(5):351-4. PubMed ID: 15190827
[TBL] [Abstract][Full Text] [Related]
10. The Tumor Suppressive Roles and Prognostic Values of STEAP Family Members in Breast Cancer.
Wu HT; Chen WJ; Xu Y; Shen JX; Chen WT; Liu J
Biomed Res Int; 2020; 2020():9578484. PubMed ID: 32802887
[TBL] [Abstract][Full Text] [Related]
11. STEAP2 Knockdown Reduces the Invasive Potential of Prostate Cancer Cells.
Burnell SEA; Spencer-Harty S; Howarth S; Bodger O; Kynaston H; Morgan C; Doak SH
Sci Rep; 2018 Apr; 8(1):6252. PubMed ID: 29674723
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression.
Saraon P; Trudel D; Kron K; Dmitromanolakis A; Trachtenberg J; Bapat B; van der Kwast T; Jarvi KA; Diamandis EP
Prostate; 2014 Apr; 74(4):372-80. PubMed ID: 24311408
[TBL] [Abstract][Full Text] [Related]
14. Expression of several cytokines in prostate cancer: Correlation with clinical variables of patients. Relationship with biochemical progression of the malignance.
Torrealba N; Rodríguez-Berriguete G; Fraile B; Olmedilla G; Martínez-Onsurbe P; Guil-Cid M; Paniagua R; Royuela M
Cytokine; 2017 Jan; 89():105-115. PubMed ID: 27527810
[TBL] [Abstract][Full Text] [Related]
15. PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study.
Kim SH; Park WS; Park BR; Joo J; Joung JY; Seo HK; Chung J; Lee KH
Asian J Androl; 2017; 19(4):458-462. PubMed ID: 27232854
[TBL] [Abstract][Full Text] [Related]
16. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
17. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
[TBL] [Abstract][Full Text] [Related]
18. Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer.
Han KR; Seligson DB; Liu X; Horvath S; Shintaku PI; Thomas GV; Said JW; Reiter RE
J Urol; 2004 Mar; 171(3):1117-21. PubMed ID: 14767283
[TBL] [Abstract][Full Text] [Related]
19. Investigating STEAP2 as a potential therapeutic target for the treatment of aggressive prostate cancer.
Jones LA; Conway GE; Nguyen-Chi A; Burnell S; Jenkins GJ; Conlan RS; Doak SH
Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):179-187. PubMed ID: 37329528
[TBL] [Abstract][Full Text] [Related]
20. Expression of prostate stem cell antigen (PSCA) in prostate cancer: a tissue microarray study of Iranian patients.
Taeb J; Asgari M; Abolhasani M; Farajollahi MM; Madjd Z
Pathol Res Pract; 2014 Jan; 210(1):18-23. PubMed ID: 24183365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]